License Agreement and Asset Acquisition - Asset Acquisition Narrative (Details) - USD ($) $ / shares in Units, $ in Thousands		1 Months Ended	3 Months Ended		9 Months Ended
	Apr. 21, 2025	Apr. 30, 2025	Sep. 30, 2025	Sep. 30, 2024	Sep. 30, 2025	Sep. 30, 2024	Dec. 31, 2024
Asset Acquisition [Line Items]
Acquired in-process research and development			$ 42,500	$ 0	$ 947,862	$ 10,000
Potential milestone payment amount			$ 8,185,879		$ 8,185,879		$ 7,713,412
Chimerix
Asset Acquisition [Line Items]
Share price (in dollars per share)		$ 8.55
Total cash consideration paid to Chimerix	$ 944,200	$ 944,154